Form
SCHEDULE 13G/A
Passive or exempt beneficial ownership filing.
DIALECTIC CAPITAL MANAGEMENT, LP - 31 Dec 2025 SCHEDULE 13G/A Report for DiaMedica Therapeutics Inc. Voting common shares, no par value per share (DMAC)
- Filing manager
- DIALECTIC CAPITAL MANAGEMENT, LP
- Reporting owner
- Dialectic Life Sciences SPV LLC
- Beneficially owned shares
- 0 shares
- Large-stake signal
-
Ownership
0%Beneficial ownership of this reported class.
Shares
0 sharesShares beneficially owned as disclosed.
Event date
31 Dec 2025Date tied to the ownership event or amendment.
Accepted by SEC
17 Feb 2026EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 0%
- Symbol
- DMAC
- SEC form
- SCHEDULE 13G/A
- Accepted by SEC
- 17 Feb 2026, 13:50:18 UTC
- Event date
- 31 Dec 2025
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
1 source field
Source evidence
Original filing metadata and source links for verification.
4 source fields
Key filing fact
DIALECTIC CAPITAL MANAGEMENT, LP disclosed 0% ownership in DiaMedica Therapeutics Inc. Voting common shares, no par value per share (DMAC) on 31 Dec 2025.
Key facts
- DIALECTIC CAPITAL MANAGEMENT, LP filed SCHEDULE 13G/A for DiaMedica Therapeutics Inc. Voting common shares, no par value per share (DMAC).
- Disclosed ownership: 0%.
- Date of event: 31 Dec 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 13:50.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (5)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Dialectic Life Sciences SPV LLC | 0% | 0 | 0 | 0 | By: /s/ Dialectic LS Manager LLC, its Managing Member | John Fichthorn / Managing Member of the Managing Member | |
| Dialectic LS Manager LLC | 0% | 0 | 0 | 0 | By: /s/ John Fichthorn | John Fichthorn / Managing Member | |
| Dialectic Capital Management, LP | 0% | 0 | 0 | 0 | By: /s/ Dialectic Partners, LLC, its General Partner | John Fichthorn / Managing Member of the General Partner | |
| Dialectic Partners, LLC | 0% | 0 | 0 | 0 | By: /s/ John Fichthorn | John Fichthorn / Managing Member | |
| John Fichthorn | 0.3% | 153,983 | 153,983 | 0 | By: /s/ John Fichthorn | John Fichthorn |
CIK / CUSIP context first